Matches in Wikidata for { <http://www.wikidata.org/entity/Q63352311> ?p ?o ?g. }
- Q63352311 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q63352311 description "article scientifique (publié 2019)" @default.
- Q63352311 description "articolo scientifico (pubblicato il 2019)" @default.
- Q63352311 description "artigo científico (publicado na 2019)" @default.
- Q63352311 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q63352311 description "artículo científico publicado en 2019" @default.
- Q63352311 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q63352311 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q63352311 description "scientific article published on 01 January 2019" @default.
- Q63352311 description "wetenschappelijk artikel" @default.
- Q63352311 description "наукова стаття, опублікована в січні 2019" @default.
- Q63352311 description "научна статия" @default.
- Q63352311 name "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 name "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 name "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 type Item @default.
- Q63352311 label "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 label "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 label "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 prefLabel "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 prefLabel "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 prefLabel "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 P1476 Q63352311-2AB5978A-1838-4D4F-AF34-77DC53C116C4 @default.
- Q63352311 P2093 Q63352311-115E8C9A-4540-492A-88A0-CE7A1E0594BD @default.
- Q63352311 P2093 Q63352311-1A97FA61-F5D1-4F22-BEE9-1D534F78EA3C @default.
- Q63352311 P2093 Q63352311-2166BC07-1A1B-419C-9554-443B02DA5A3D @default.
- Q63352311 P2093 Q63352311-3A5FD3E9-C1B5-4B67-BC89-FFC7929C0E4A @default.
- Q63352311 P2093 Q63352311-4259DA42-6C6A-4CFD-AF0C-5F681DB5612C @default.
- Q63352311 P2093 Q63352311-50370151-FE66-476C-BF33-95C576E58AEA @default.
- Q63352311 P2093 Q63352311-6B07BB03-A54C-4CF3-AC57-8058985FFFA2 @default.
- Q63352311 P2093 Q63352311-B65CDDAE-8D1C-4EB5-92D8-8BD6BB7DDA35 @default.
- Q63352311 P2093 Q63352311-BF421635-C62F-44D5-96DE-DA60D17A7EB3 @default.
- Q63352311 P2093 Q63352311-EAC8C857-B127-4E79-84BF-5E773DD7951C @default.
- Q63352311 P2093 Q63352311-F2F4AA0E-BCAB-4193-85F9-CF586E23EAEA @default.
- Q63352311 P2860 Q63352311-6CAFC311-F784-43DF-A164-0BA32B0430A5 @default.
- Q63352311 P2860 Q63352311-96B6243D-F754-483C-84E6-97A7ABC91674 @default.
- Q63352311 P2860 Q63352311-A448BE5C-4D15-4B12-866B-B771F9D74E8E @default.
- Q63352311 P2860 Q63352311-E3AF4FBD-612B-4E96-8A2F-44CB2C4BA191 @default.
- Q63352311 P2860 Q63352311-F2ACE582-8308-45DD-8BBF-DE01FF53DE7F @default.
- Q63352311 P304 Q63352311-0A2AA54F-FCBA-4854-AD5D-EDEDE0EB52EA @default.
- Q63352311 P31 Q63352311-71F7FD56-8297-4F5B-95B4-B39475219967 @default.
- Q63352311 P356 Q63352311-60E59C66-DF33-4417-92E1-D004167AB249 @default.
- Q63352311 P433 Q63352311-F88EC5EE-B52B-4FEC-8217-12AD2D70F03D @default.
- Q63352311 P478 Q63352311-57C0A7C5-B6DB-4AB5-A9D5-0F66A10ABD1F @default.
- Q63352311 P50 Q63352311-090D4FDB-A252-4078-8EEC-AD9DCB0E252B @default.
- Q63352311 P50 Q63352311-275FF20C-F1E4-415A-B243-B3A0EDCF0BA5 @default.
- Q63352311 P50 Q63352311-2BEF7B56-0A47-4895-A428-4F858375BE7F @default.
- Q63352311 P50 Q63352311-44E83757-450F-49F9-A214-262ECB7ECE26 @default.
- Q63352311 P50 Q63352311-521D10BF-FD70-4461-9EF5-6F8FD53080FA @default.
- Q63352311 P50 Q63352311-5374C978-ADB5-4E9F-B19C-E79FD34091F9 @default.
- Q63352311 P50 Q63352311-67DE985E-4264-4E24-A415-298C4810D01D @default.
- Q63352311 P50 Q63352311-820B17F1-1E20-4BB8-A0BD-0BAF8F438882 @default.
- Q63352311 P50 Q63352311-A204B8A6-4C88-4349-AE05-ABDA172D3BC7 @default.
- Q63352311 P50 Q63352311-AF935C7A-C471-4DB6-AF90-4C69F7605A74 @default.
- Q63352311 P50 Q63352311-C67D2FDE-9DC9-4384-A739-337D2F6DFB8C @default.
- Q63352311 P50 Q63352311-CD26FF9A-3603-4D10-B613-956A4588276D @default.
- Q63352311 P50 Q63352311-D408751A-7A33-437C-B61E-4EEA707A93BA @default.
- Q63352311 P577 Q63352311-2AB81098-B1EC-49F8-8481-E9D319054F62 @default.
- Q63352311 P698 Q63352311-D9544CFE-7B42-408B-8773-E08235E7BBDF @default.
- Q63352311 P921 Q63352311-9014C4D6-6529-4420-9F89-579D8F5AB3B6 @default.
- Q63352311 P932 Q63352311-A6E14C07-02FD-4382-84C3-D8D7226A5E0F @default.
- Q63352311 P356 CIRCGEN.118.002335 @default.
- Q63352311 P698 30645169 @default.
- Q63352311 P1476 "Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition" @default.
- Q63352311 P2093 "Ben M Brumpton" @default.
- Q63352311 P2093 "Cristen Willer" @default.
- Q63352311 P2093 "Ferdinand M Van't Hooft" @default.
- Q63352311 P2093 "Gunnhild Åberge Vie" @default.
- Q63352311 P2093 "Humaira Rasheed" @default.
- Q63352311 P2093 "INVENT Consortium" @default.
- Q63352311 P2093 "Jie Zheng" @default.
- Q63352311 P2093 "Jonas Bille Nielsen" @default.
- Q63352311 P2093 "Maiken Elvestad Gabrielsen" @default.
- Q63352311 P2093 "Maria Mannila" @default.
- Q63352311 P2093 "Sarah E Graham" @default.
- Q63352311 P2860 Q35266365 @default.
- Q63352311 P2860 Q40427339 @default.
- Q63352311 P2860 Q51302187 @default.
- Q63352311 P2860 Q55427190 @default.
- Q63352311 P2860 Q91242823 @default.
- Q63352311 P304 "e002335" @default.
- Q63352311 P31 Q13442814 @default.
- Q63352311 P356 "10.1161/CIRCGEN.118.002335" @default.
- Q63352311 P433 "1" @default.
- Q63352311 P478 "12" @default.
- Q63352311 P50 Q114339488 @default.
- Q63352311 P50 Q11978898 @default.
- Q63352311 P50 Q12006168 @default.
- Q63352311 P50 Q21003878 @default.
- Q63352311 P50 Q29839641 @default.
- Q63352311 P50 Q3218159 @default.
- Q63352311 P50 Q32984975 @default.
- Q63352311 P50 Q3334710 @default.
- Q63352311 P50 Q41607561 @default.
- Q63352311 P50 Q47452535 @default.
- Q63352311 P50 Q47504859 @default.
- Q63352311 P50 Q47504873 @default.
- Q63352311 P50 Q64981181 @default.
- Q63352311 P577 "2019-01-01T00:00:00Z" @default.
- Q63352311 P698 "30645169" @default.